Connecticut 2021 Regular Session

Connecticut Senate Bill SB00202 Latest Draft

Bill / Introduced Version Filed 01/21/2021

                             
 
LCO No. 671   	1 of 2 
 
General Assembly  Proposed Bill No. 202  
January Session, 2021  
LCO No. 671 
 
 
Referred to Committee on INSURANCE AND REAL ESTATE  
 
 
Introduced by:  
SEN. LOONEY, 11th Dist. 
 
 
 
AN ACT CONCERNING STEP THERAPY, ADVERSE DETERMINATION 
AND UTILIZATION REVIEWS, AND REQUIRED HEALTH INSURANCE 
COVERAGE FOR CHILDREN, STEPCHILDREN AND OTHER 
DEPENDENT CHILDREN. 
Be it enacted by the Senate and House of Representatives in General 
Assembly convened: 
 
That title 38a of the general statutes be amended to: (1) Prohibit health 1 
carriers from requiring the use of step therapy for drugs prescribed to 2 
treat disabling, chronic or life-threatening diseases or conditions; (2) 3 
require that health carriers bear the burden of proving that certain 4 
health care services under adverse determination or utilization review 5 
are not medically necessary; (3) redefine "clinical peer" for the purposes 6 
of adverse determination and utilization reviews; (4) require health 7 
carriers to provide certain clinical peers with the authority to reverse 8 
initial adverse determinations; and (5) allow children, stepchildren and 9 
other dependent children to retain health insurance coverage under 10 
their parents' insurance policies until the end of the policy year during 11 
which they attain the age of twenty-six. 12  Proposed Bill No.  202 
 
 
LCO No. 671   	2 of 2 
 
Statement of Purpose:   
To: (1) Prohibit health carriers from requiring the use of step therapy for 
drugs prescribed to treat disabling, chronic or life-threatening diseases 
or conditions; (2) require that health carriers bear the burden of proving 
that certain health care services under adverse determination or 
utilization review are not medically necessary; (3) redefine "clinical 
peer" for the purposes of adverse determination and utilization reviews; 
(4) require health carriers to provide certain clinical peers with the 
authority to reverse initial adverse determinations; and (5) allow 
children, stepchildren and other dependent children to retain health 
insurance coverage under their parents' insurance policies until the end 
of the policy year during which they attain the age of twenty-six.